US 5,317,085 AGranted

Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response

AssigneeThe Brigham and Women's Hospital, Inc.

InventorsRichard L. Stevens, John H. Weis, Christopher F. Nicodemus

Life of this patent

Estimating the term…

Abstract

This invention relates to the identification, characterization, and sequencing of genetic sequences of human secretory granule proteoglycan peptide core protein, recombinant DNA clones directed against this sequence and against the sequence of the antisense RNA, and antibodies which recognize the native human secretory granule proteoglycan.

Claims2

Dependent claims

A peptide of the formula SVQGYPTQRARYQWVR.

Dependencies are inferred from the claim text.

Facts

Application: 07/909,644Filed 7 Jul 1992 · division
Priority: 13 Jul 1988
Granted: 31 May 1994
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07K 14/47
From vertebrates: from mammals
C07K 16/18
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies: against material from animals or humans
C12N 15/85
Vectors or expression systems specially adapted for eukaryotic hosts: for animal cells
Y10S 530/806
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof: antigenic peptides or proteins

Family

Serial224,035Parent of this continuation-in-part · filed 13 Jul 1988
Serial635,544Parent of this division · filed 18 Jan 1991
US 5,171,674 AParent of this division
US 5,317,085 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results